Skip to Main Content

Paper Details

Cardiovascular and kidney outcomes with canagliflozin according to type 2 diabetes treatment targets at baseline: Data from the CANVAS programme and CREDENCE.
Diabetes Obes Metab
0
2023
Author NameAffiliation
Sheldon W TobeSunnybrook Research Institute
Sheldon W TobeNorthern Ontario School of Medicine
Kenneth W MahaffeyStanford Center for Clinical Research, Stanford University School of Medicine
  • 1 - 3

Datasets

Release 1.2